A new study from Denmark showed that after taking eye drops that helps prevent longsightedness, most participants were able ...

A study of 766 patients suggested that specially formulated eye drops improved near vision for over 80% of presbyopia ...

Trials of vision-improving substances are showing good results, though so far only two have been authorized for use in the ...

Despite possessing a solid data package on the potential of high-dose Sprinraza in spinal muscular atrophy (SMA), Biogen will now need to revise its application if it hopes to secure an FDA nod. The ...

It’s becoming increasingly clear that pharmaceutical companies can live with President Trump’s tariffs. What the industry can’t live with is uncertainty on drug prices. The sector has long traded at a ...

The White House has proposed good and bad ideas to reduce drug costs. Among the better ones is a reform of the obscure 340B drug program, which enriches large hospitals at the expense of patients. Cue ...

As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...

This week, the Trump administration announced that the FDA had approved leucovorin, a generic drug, as a treatment for autism. The announcement shocked health experts because the FDA’s usual approval ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Crinetics Pharmaceuticals won Food and Drug Administration approval on ...

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the injections stop. A new drug targets weight loss differently, leading to a more ...